"This is a cannabis stock" -- not a medical marijuana stock, he argued. He said GW Pharma is "a real company" that has other business segments, while also having operations in the medical marijuana field.
"I am shocked at this" bold and timely analyst action, Cramer concluded, calling GW Pharma his favorite cannabis stock.
-- Written by Bret Kenwell in Petoskey, Mich. Follow @BretKenwell